Literature DB >> 3971598

Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig.

R D Aldridge, A W Thomson, R Rankin, P H Whiting, C Cunningham, J G Simpson.   

Abstract

Contact sensitivity skin reactions to dinitrofluorobenzene (DNFB) were inhibited by twice daily topical application of cyclosporin (CsA, 2%) in normal guinea-pigs and in those with enhanced contact sensitivity reactions following pre-treatment with cyclophosphamide. In contrast to oral administration of CsA (25 mg/kg) for 4 days, topical application of the drug over the same period did not result in systemic absorption (as measured by radioimmunoassay) or in any evidence of nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971598      PMCID: PMC1577184     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Absence of dependence on cyclophosphamide-sensitive suppressor cells in suppression of cell-mediated immunity by cyclosporine in the guinea pig.

Authors:  A W Thomson; R D Aldridge
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

Review 2.  Immunobiology of cyclosporin A--a review.

Authors:  A W Thomson
Journal:  Aust J Exp Biol Med Sci       Date:  1983-04

3.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

4.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

5.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

6.  Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.

Authors:  A W Thomson; P H Whiting; J T Blair; R J Davidson; J G Simpson
Journal:  Transplantation       Date:  1981-10       Impact factor: 4.939

7.  Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig.

Authors:  D Parker; K Drössler; J L Turk
Journal:  Int J Immunopharmacol       Date:  1984

8.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

9.  Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

Authors:  P A Hunter; K R Wilhelmus; N S Rice; B R Jones
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

Review 10.  Effect of cyclophosphamide on immunological control mechanisms.

Authors:  J L Turk; D Parker
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

  10 in total
  4 in total

1.  Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function.

Authors:  J Péguet-Navarro; M Slaats; J Thivolet
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Immunohistochemical analysis of contact sensitivity reactions in the guinea-pig using novel monoclonal antibodies: the influence of topical cyclosporin A.

Authors:  S N Payne; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation.

Authors:  R D Aldridge; H F Sewell; G King; A W Thomson
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

4.  Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.

Authors:  M Braida; J Knop
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.